CO6190600A2 - Metodo para formar una tableta que comprende el premezclado de ibuprofeno y silice - Google Patents
Metodo para formar una tableta que comprende el premezclado de ibuprofeno y siliceInfo
- Publication number
- CO6190600A2 CO6190600A2 CO09068966A CO09068966A CO6190600A2 CO 6190600 A2 CO6190600 A2 CO 6190600A2 CO 09068966 A CO09068966 A CO 09068966A CO 09068966 A CO09068966 A CO 09068966A CO 6190600 A2 CO6190600 A2 CO 6190600A2
- Authority
- CO
- Colombia
- Prior art keywords
- mixing
- tablet
- premixing
- forming
- minutes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1.- Un método para formar una tableta, que comprende las etapas de premezclar un ingrediente activo farmacéuticamente susceptible a la adhesividad y un aditivo de mezclado, con un primer esfuerzo mezclador para formar una mezcla premezclada, en donde el primer esfuerzo mezclador y un segundo esfuerzo mezclador, resultantes del mezclado de al menos un excipiente con la mezcla premezclada, formando una mezcla adecuada para la compresión directa, y comprimir dicha mezcla para formar dicha tableta. 2.- El método de la reivindicación 1, en donde dicho ingrediente activo farmacéuticamente comprende ibuprofeno. 3.- El método de la reivindicación 1, en donde dicho aditivo de mezclado comprende sílice, celulosa microcristalina silicificada o una combinación de los mismos. 4.- El método de la reivindicación 1, en donde dicho aditivo de mezclado comprende sílice. 5.- El método de la reivindicación 2, en donde la etapa de premezclado comprende premezclar durante un tiempo entre 20 minutos y 90 minutos. 6.- El método de la reivindicación 2, en donde la etapa de premezclado comprende premezclar durante un tiempo entre 40 minutos y 60 minutos. 7.- El método de la reivindicación 1, en donde dicho aditivo de mezclado se encuentra presente en una concentración en el rango de 0.1% a 10% por peso de dicho ingrediente activo farmacéuticamente. 8.- El método de la reivindicación 2, en donde dicho aditivo de mezclado se encuentra presente en una concentración en el rango de 0.5% a 1.5% por peso de dicho ingrediente activo farmacéuticamente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/633,322 US20070077297A1 (en) | 2004-09-30 | 2006-12-04 | Modified release ibuprofen dosage form |
US11/906,303 US7749537B2 (en) | 2006-12-04 | 2007-10-01 | Method of forming a tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6190600A2 true CO6190600A2 (es) | 2010-08-19 |
Family
ID=39492797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09068966A CO6190600A2 (es) | 2006-12-04 | 2009-07-03 | Metodo para formar una tableta que comprende el premezclado de ibuprofeno y silice |
Country Status (12)
Country | Link |
---|---|
US (1) | US7749537B2 (es) |
EP (1) | EP2099432B1 (es) |
JP (1) | JP2010511613A (es) |
KR (1) | KR20090090369A (es) |
AU (1) | AU2007328390B2 (es) |
BR (1) | BRPI0717914A2 (es) |
CA (1) | CA2671420A1 (es) |
CO (1) | CO6190600A2 (es) |
MX (1) | MX2009005959A (es) |
PL (1) | PL2099432T3 (es) |
TW (1) | TW200831136A (es) |
WO (1) | WO2008069938A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT2487161T (lt) | 2007-02-23 | 2016-11-10 | Gilead Sciences, Inc. | Terapinių agentų farmakokinetinių savybių moduliatoriai |
JP5722213B2 (ja) * | 2008-05-02 | 2015-05-20 | ギリアード サイエンシーズ, インコーポレイテッド | 医薬薬剤の加工性を改良するための固体担体粒子の使用 |
TWI478733B (zh) * | 2009-05-13 | 2015-04-01 | Wyeth Llc | 突釋藥物釋放組合物 |
ES2363964B1 (es) | 2009-11-20 | 2012-08-22 | Gp Pharm, S.A. | Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados. |
WO2013154511A1 (en) * | 2012-04-13 | 2013-10-17 | Mahmut Bilgic | Film tablet formulations comprising dexibuprofen |
AU2014233139A1 (en) * | 2013-03-15 | 2016-01-21 | Mylan Inc. | Manufacturing process for effervescent dosage forms |
US20140322386A1 (en) * | 2013-04-24 | 2014-10-30 | Northern Brewer Llc | Beer brewing additive and method |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4609675A (en) * | 1984-08-17 | 1986-09-02 | The Upjohn Company | Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing |
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
ATE50493T1 (de) * | 1986-11-14 | 1990-03-15 | Puetter Medice Chem Pharm | Ibuprofen enthaltendes arzneimittel. |
US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
US4806359A (en) | 1987-04-22 | 1989-02-21 | Mcneilab, Inc. | Iburprofen sustained release matrix and process |
US5200193A (en) * | 1987-04-22 | 1993-04-06 | Mcneilab, Inc. | Pharmaceutical sustained release matrix and process |
EP0297866A3 (en) | 1987-07-01 | 1989-12-13 | The Boots Company PLC | Therapeutic agents |
SE463541B (sv) * | 1987-08-31 | 1990-12-10 | Lejus Medical Ab | Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning |
US4814181A (en) * | 1987-09-03 | 1989-03-21 | Alza Corporation | Dosage form comprising fast agent delivery followed by slow agent delivery |
US4916161A (en) * | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
US5104648A (en) * | 1989-02-02 | 1992-04-14 | Mallinckrodt Specialty Chemicals Company | High ibuprofen content granulations |
US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
US5087454A (en) * | 1990-07-30 | 1992-02-11 | American Home Products Corporation | Ibuprofen tablet |
JPH069382A (ja) * | 1992-04-17 | 1994-01-18 | Takeda Chem Ind Ltd | 安定化された固型製剤およびその製造方法 |
US5429825A (en) * | 1992-06-26 | 1995-07-04 | Mcneil-Ppc, Inc. | Rotomelt granulation |
US5512300A (en) * | 1992-09-15 | 1996-04-30 | Warner-Lambert Company | Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms |
GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
US6348216B1 (en) * | 1996-06-10 | 2002-02-19 | Knoll Pharmaceutical Company | Ibuprofen and narcotic analgesic compositions |
US6361794B1 (en) * | 1996-06-12 | 2002-03-26 | Basf Corporation | Method of making ibuprofen and narcotic analgesic composition |
US5830503A (en) * | 1996-06-21 | 1998-11-03 | Andrx Pharmaceuticals, Inc. | Enteric coated diltiazem once-a-day formulation |
JP3148256B2 (ja) * | 1996-07-08 | 2001-03-19 | エドワード メンデル カンパニー.,インコーポレーテッド | 高用量難溶性薬物用持続放出マトリックス |
GB9702392D0 (en) | 1997-02-06 | 1997-03-26 | Boots Co Plc | Therapeutic agents |
US6210710B1 (en) * | 1997-04-28 | 2001-04-03 | Hercules Incorporated | Sustained release polymer blend for pharmaceutical applications |
ES2234139T3 (es) * | 1997-08-11 | 2005-06-16 | Alza Corporation | Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica. |
NZ333474A (en) * | 1998-01-02 | 1999-06-29 | Mcneil Ppc Inc | A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat |
US20030153623A1 (en) * | 1998-07-22 | 2003-08-14 | Yamanouchi Pharmaceutical Co., Ltd. | Solid preparation containing sparingly soluble NSAIDs |
WO2000054752A1 (fr) * | 1999-03-15 | 2000-09-21 | Kaken Pharmaceutical Co., Ltd. | Comprimes a delitement rapide et procede de fabrication |
WO2001022939A1 (en) * | 1999-09-29 | 2001-04-05 | Fmc Corporation | Hydrolyzed cellulose granulations of salts of drugs |
US20030045508A1 (en) * | 1999-12-10 | 2003-03-06 | Daluge Susan Mary | (1r,cis)-4-(4-amino-7h-pyrrolo'2,3-i(d) pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral |
DE10001166A1 (de) * | 2000-01-13 | 2001-07-19 | Merckle Gmbh | Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung |
DE10003757A1 (de) | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen-Wirkstoffzubereitung |
US6623756B1 (en) * | 2000-04-27 | 2003-09-23 | Noveon Ip Holdings Corp. | Directly compressed solid dosage articles |
US20030175349A1 (en) | 2001-01-30 | 2003-09-18 | Council Of Scientific And Industrial Research | Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient |
GB0108930D0 (en) * | 2001-04-10 | 2001-05-30 | Boots Co Plc | Therapeutic agents |
GB0113841D0 (en) * | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
US6547182B2 (en) * | 2001-07-19 | 2003-04-15 | Aerojet-General Corporation | Solid rocket motor bolted thrust takeout structure |
WO2003017981A1 (en) * | 2001-08-29 | 2003-03-06 | Ranbaxy Laboratories Limited | Controlled release formulation of clarithromycin or tinidazol |
US6592901B2 (en) * | 2001-10-15 | 2003-07-15 | Hercules Incorporated | Highly compressible ethylcellulose for tableting |
EP1444978A1 (en) | 2001-11-13 | 2004-08-11 | Kyowa Hakko Kogyo Co., Ltd. | Amino acid-containing tablets quickly disintegrating in the oral cavity and process for producing the same |
US6866070B2 (en) * | 2002-08-08 | 2005-03-15 | Glen Ellyn Industries Llc | Bag insert and support |
CH693586A8 (de) * | 2002-10-14 | 2003-12-15 | Roche Consumer Health Ag | Darreichungsform von Ibuprofen-Natrium. |
US20040096497A1 (en) * | 2002-11-19 | 2004-05-20 | Ponder Garratt W. | Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions |
MXPA05005781A (es) * | 2002-11-29 | 2005-12-12 | Forest Laboratories | Combinacion de ibuprofeno y oxicodona para alivio de dolor agudo. |
WO2005000237A2 (en) * | 2003-06-25 | 2005-01-06 | University Of Tennessee Research Foundation | Granules containing biologically active substances |
US20070077297A1 (en) * | 2004-09-30 | 2007-04-05 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
US20060068009A1 (en) | 2004-09-30 | 2006-03-30 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
JP5026675B2 (ja) * | 2005-03-08 | 2012-09-12 | 洋文 竹内 | 錠剤、およびその製造方法 |
DE102005049001A1 (de) * | 2005-10-11 | 2007-04-12 | Basf Ag | Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen |
-
2007
- 2007-10-01 US US11/906,303 patent/US7749537B2/en not_active Expired - Fee Related
- 2007-11-28 KR KR1020097014021A patent/KR20090090369A/ko not_active Application Discontinuation
- 2007-11-28 BR BRPI0717914-6A patent/BRPI0717914A2/pt not_active IP Right Cessation
- 2007-11-28 EP EP07862281A patent/EP2099432B1/en not_active Not-in-force
- 2007-11-28 PL PL07862281T patent/PL2099432T3/pl unknown
- 2007-11-28 AU AU2007328390A patent/AU2007328390B2/en not_active Ceased
- 2007-11-28 WO PCT/US2007/024489 patent/WO2008069938A2/en active Application Filing
- 2007-11-28 CA CA002671420A patent/CA2671420A1/en not_active Abandoned
- 2007-11-28 MX MX2009005959A patent/MX2009005959A/es active IP Right Grant
- 2007-11-28 JP JP2009539301A patent/JP2010511613A/ja active Pending
- 2007-12-04 TW TW096146118A patent/TW200831136A/zh unknown
-
2009
- 2009-07-03 CO CO09068966A patent/CO6190600A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2671420A1 (en) | 2008-06-12 |
JP2010511613A (ja) | 2010-04-15 |
KR20090090369A (ko) | 2009-08-25 |
MX2009005959A (es) | 2010-12-20 |
AU2007328390B2 (en) | 2012-11-15 |
BRPI0717914A2 (pt) | 2013-11-05 |
WO2008069938A2 (en) | 2008-06-12 |
PL2099432T3 (pl) | 2013-04-30 |
EP2099432B1 (en) | 2012-11-14 |
AU2007328390A1 (en) | 2008-06-12 |
US20080131507A1 (en) | 2008-06-05 |
TW200831136A (en) | 2008-08-01 |
WO2008069938A3 (en) | 2008-10-09 |
US7749537B2 (en) | 2010-07-06 |
EP2099432A2 (en) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6190600A2 (es) | Metodo para formar una tableta que comprende el premezclado de ibuprofeno y silice | |
BRPI0514474A (pt) | multiparticulados | |
UY30444A1 (es) | Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. | |
GT200600096A (es) | Composicion farmaceutica para el tratamiento del cancer | |
AR049000A1 (es) | Formulacion para compresion directa y proceso para la preparacion de una tableta directamente comprimida | |
CO6160317A2 (es) | Formas de dosificacion farmaceutica no manipulables que incluyen un analgesico opioide | |
CR9723A (es) | Nueva forma cristalina de un derivado de piridazino[4,5-b] indol | |
ECSP099750A (es) | Imidazoquinolinas con propiedades inmunomoduladoras | |
PA8849701A1 (es) | Forma de dosificacion farmaceutica que comprende nifedipino o nisoldipino y un antagonista de anglotensina ii y/o un diuretico | |
PA8565501A1 (es) | Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas | |
BR112012007412A2 (pt) | tabletes transformáveis de forma oral. | |
GT201000008A (es) | Agentes citotoxicos que comprenden nuevos derivados de tomaimicina y su uso terapeutico | |
ECSP088281A (es) | Moduladores del metabolismo y tratamiento de los trastornos metabólicos | |
GT200600445A (es) | Formas de presentación farmaceuticas solidas de administración oral con liberacion rapida del principio activo. | |
CO6400186A2 (es) | Tabletas de acetato de ulipristal | |
CR9339A (es) | Formas farmaceuticas con propiedades farmacocineticas mejoradas | |
AR070783A1 (es) | Forma de cristal de derivados de fenilamina-pirimidina | |
ECSP088889A (es) | Forma nueva de administración de racecadotril | |
ECSP11011082A (es) | Compuestos, composición farmaceutica y métodos para utilizarse en el tratamiento de desórdenes metabólicos | |
UY32624A (es) | Procedimiento y composición para mejorar la absorción de agentes terapéuticos | |
GT200600369A (es) | Proceso | |
EA201690810A1 (ru) | Мягкие пастилки, содержащие экстракт куркумы | |
ECSP088569A (es) | Nuevos derivados de furopirimidina acíclicos sustituidos y uso de los mismos para el tratamiento de enfermedades cardiovasculares | |
BR112015001640A2 (pt) | formulações e métodos de produção de formulações para uso em evacuação colônica | |
PE20090371A1 (es) | Formulacion de nevirapina de liberacion prolongada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |